WP
Woodline Partners’s Axsome Therapeutics AXSM Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $34.6M | Buy |
331,131
+27,047
| +9% | +$2.82M | 0.18% | 155 |
|
2025
Q1 | $35.5M | Sell |
304,084
-104,357
| -26% | -$12.2M | 0.23% | 137 |
|
2024
Q4 | $34.6M | Buy |
408,441
+109,872
| +37% | +$9.3M | 0.23% | 135 |
|
2024
Q3 | $26.8M | Sell |
298,569
-19,442
| -6% | -$1.75M | 0.23% | 145 |
|
2024
Q2 | $25.6M | Sell |
318,011
-42,117
| -12% | -$3.39M | 0.24% | 130 |
|
2024
Q1 | $28.7M | Sell |
360,128
-202,035
| -36% | -$16.1M | 0.26% | 116 |
|
2023
Q4 | $44.7M | Buy |
562,163
+110,056
| +24% | +$8.76M | 0.49% | 61 |
|
2023
Q3 | $31.6M | Buy |
452,107
+12,182
| +3% | +$851K | 0.37% | 66 |
|
2023
Q2 | $31.6M | Sell |
439,925
-130,900
| -23% | -$9.41M | 0.37% | 71 |
|
2023
Q1 | $35.2M | Buy |
570,825
+347,173
| +155% | +$21.4M | 0.48% | 50 |
|
2022
Q4 | $17.3M | Buy |
+223,652
| New | +$17.3M | 0.23% | 131 |
|